Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

North Carolina's life sciences sector continues to attract major investments with the potential for thousands of jobs.

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...

Headlines across North Carolina Monday and Tuesday included 400 new jobs in Holly Springs; flooding risk in the mountains eases; Congressman Chuck Edwards accused for hitting someone with a clipboard ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity financing and announced additional milestones since the start of ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...

Less than a month after announcing a $50 billion investment in its U.S. operations over the next five years, Swiss pharma ...

The U.S. secured over $1 billion in new manufacturing investment today on the back of President Trump’s push for more domestic production. Receive undervalued stocks, resilient to market uncertainty, ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...